

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of chronic inflammatory response (GO:0002676) | 6.19987975 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.87443335 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.70690091 |
| 4 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.70690091 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.15749618 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.10038777 |
| 7 | positive regulation of heat generation (GO:0031652) | 4.90408192 |
| 8 | positive regulation of defense response to virus by host (GO:0002230) | 4.77144797 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.71809202 |
| 10 | regulation of fever generation (GO:0031620) | 4.68509227 |
| 11 | regulation of vitamin metabolic process (GO:0030656) | 4.64000895 |
| 12 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.57984988 |
| 13 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.30722454 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.24546787 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.24546787 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 4.24546787 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 4.24546787 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 4.24546787 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.24546787 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.17744319 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 4.16523155 |
| 22 | regulation of chemokine biosynthetic process (GO:0045073) | 4.12592810 |
| 23 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.11501985 |
| 24 | T-helper 1 type immune response (GO:0042088) | 4.10827282 |
| 25 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 4.08301923 |
| 26 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.06919131 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.97173851 |
| 28 | kynurenine metabolic process (GO:0070189) | 3.96224586 |
| 29 | tryptophan catabolic process (GO:0006569) | 3.95427565 |
| 30 | indole-containing compound catabolic process (GO:0042436) | 3.95427565 |
| 31 | indolalkylamine catabolic process (GO:0046218) | 3.95427565 |
| 32 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93787105 |
| 33 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.91604991 |
| 34 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.90869632 |
| 35 | regulation of heat generation (GO:0031650) | 3.88734249 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.88210136 |
| 37 | regulation of interleukin-12 production (GO:0032655) | 3.87547797 |
| 38 | regulation of T-helper cell differentiation (GO:0045622) | 3.85957200 |
| 39 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.79409969 |
| 40 | positive regulation of interleukin-12 production (GO:0032735) | 3.78670326 |
| 41 | negative regulation of viral genome replication (GO:0045071) | 3.75849978 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 3.73658982 |
| 43 | neutrophil activation involved in immune response (GO:0002283) | 3.72952417 |
| 44 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.71371130 |
| 45 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.70875900 |
| 46 | regulation of T-helper 1 type immune response (GO:0002825) | 3.69532047 |
| 47 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.68617091 |
| 48 | defense response to protozoan (GO:0042832) | 3.64011728 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.62938063 |
| 50 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.62363302 |
| 51 | regulation of B cell differentiation (GO:0045577) | 3.59647958 |
| 52 | respiratory burst (GO:0045730) | 3.58454915 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.56656093 |
| 54 | response to peptidoglycan (GO:0032494) | 3.56243016 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.54675158 |
| 56 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.53098299 |
| 57 | negative regulation of growth of symbiont in host (GO:0044130) | 3.52607037 |
| 58 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.52607037 |
| 59 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.52607037 |
| 60 | regulation of growth of symbiont in host (GO:0044126) | 3.52607037 |
| 61 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.51308675 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.49949606 |
| 63 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.48721867 |
| 64 | regulation of defense response to virus by host (GO:0050691) | 3.46146520 |
| 65 | positive regulation of type 2 immune response (GO:0002830) | 3.46114369 |
| 66 | regulation of gamma-delta T cell activation (GO:0046643) | 3.43027497 |
| 67 | response to type I interferon (GO:0034340) | 3.42741763 |
| 68 | response to protozoan (GO:0001562) | 3.42545071 |
| 69 | type I interferon signaling pathway (GO:0060337) | 3.42463473 |
| 70 | cellular response to type I interferon (GO:0071357) | 3.42463473 |
| 71 | response to muramyl dipeptide (GO:0032495) | 3.42381319 |
| 72 | leukocyte aggregation (GO:0070486) | 3.38970014 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.37686996 |
| 74 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.37654244 |
| 75 | positive regulation of interferon-alpha production (GO:0032727) | 3.37489955 |
| 76 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.37367473 |
| 77 | negative regulation of cell killing (GO:0031342) | 3.37367473 |
| 78 | tryptophan metabolic process (GO:0006568) | 3.34037607 |
| 79 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.33507919 |
| 80 | regulation of immunoglobulin secretion (GO:0051023) | 3.33353385 |
| 81 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.32284555 |
| 82 | ribosomal small subunit assembly (GO:0000028) | 3.32180018 |
| 83 | cellular response to nicotine (GO:0071316) | 3.29313630 |
| 84 | NIK/NF-kappaB signaling (GO:0038061) | 3.29298845 |
| 85 | positive regulation of prostaglandin secretion (GO:0032308) | 3.28768956 |
| 86 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.26204084 |
| 87 | regulation of integrin activation (GO:0033623) | 3.26148161 |
| 88 | myeloid dendritic cell differentiation (GO:0043011) | 3.26029054 |
| 89 | macrophage activation involved in immune response (GO:0002281) | 3.25503368 |
| 90 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.24647019 |
| 91 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.24596308 |
| 92 | myeloid dendritic cell activation (GO:0001773) | 3.24571655 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 3.23805159 |
| 94 | B cell mediated immunity (GO:0019724) | 3.23678096 |
| 95 | regulation of interferon-alpha production (GO:0032647) | 3.23643631 |
| 96 | cellular extravasation (GO:0045123) | 3.22507303 |
| 97 | negative regulation of phagocytosis (GO:0050765) | 3.18186402 |
| 98 | negative regulation of interleukin-10 production (GO:0032693) | 3.17092698 |
| 99 | B cell receptor signaling pathway (GO:0050853) | 3.16565123 |
| 100 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.16230329 |
| 101 | interferon-gamma secretion (GO:0072643) | 3.16110774 |
| 102 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.14409517 |
| 103 | germinal center formation (GO:0002467) | 3.13356049 |
| 104 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.12958694 |
| 105 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.12935351 |
| 106 | cellular response to exogenous dsRNA (GO:0071360) | 3.11027407 |
| 107 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.07047620 |
| 108 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.06743132 |
| 109 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.06725233 |
| 110 | viral transcription (GO:0019083) | 3.06517046 |
| 111 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.03590319 |
| 112 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.02642812 |
| 113 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.01507943 |
| 114 | negative regulation of amino acid transport (GO:0051956) | 3.00432166 |
| 115 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.00209853 |
| 116 | leukocyte cell-cell adhesion (GO:0007159) | 2.98133012 |
| 117 | negative regulation of T cell mediated immunity (GO:0002710) | 2.97467048 |
| 118 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.97307631 |
| 119 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.97158488 |
| 120 | regulation of natural killer cell activation (GO:0032814) | 2.96801757 |
| 121 | response to interferon-beta (GO:0035456) | 2.95841285 |
| 122 | regulation of prostaglandin secretion (GO:0032306) | 2.95678736 |
| 123 | cellular response to zinc ion (GO:0071294) | 2.95407644 |
| 124 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.95034793 |
| 125 | mature B cell differentiation (GO:0002335) | 2.94971320 |
| 126 | positive regulation of natural killer cell activation (GO:0032816) | 2.94800258 |
| 127 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.93089643 |
| 128 | positive regulation of interleukin-17 production (GO:0032740) | 2.93037593 |
| 129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.92982513 |
| 130 | T cell migration (GO:0072678) | 2.92736263 |
| 131 | cellular response to ATP (GO:0071318) | 2.92403974 |
| 132 | positive regulation of interferon-gamma production (GO:0032729) | 2.92195811 |
| 133 | positive regulation of acute inflammatory response (GO:0002675) | 2.91764445 |
| 134 | positive regulation of mast cell activation (GO:0033005) | 2.91441092 |
| 135 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.91108584 |
| 136 | regulation of podosome assembly (GO:0071801) | 2.90777399 |
| 137 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.90464727 |
| 138 | T-helper cell differentiation (GO:0042093) | 2.90464727 |
| 139 | response to interferon-alpha (GO:0035455) | 2.87190039 |
| 140 | interferon-gamma production (GO:0032609) | 2.87154769 |
| 141 | regulation of T cell tolerance induction (GO:0002664) | 2.86955344 |
| 142 | negative regulation of granulocyte differentiation (GO:0030853) | 2.86152275 |
| 143 | myeloid cell activation involved in immune response (GO:0002275) | 2.85985911 |
| 144 | translational termination (GO:0006415) | 2.85481478 |
| 145 | regulation of antigen processing and presentation (GO:0002577) | 2.85118083 |
| 146 | DNA deamination (GO:0045006) | 2.83242939 |
| 147 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81081316 |
| 148 | mannose metabolic process (GO:0006013) | 2.79483229 |
| 149 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.78633004 |
| 150 | dendritic cell differentiation (GO:0097028) | 2.77026721 |
| 151 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.76685159 |
| 152 | tolerance induction (GO:0002507) | 2.76107157 |
| 153 | neutrophil activation (GO:0042119) | 2.74005143 |
| 154 | mature B cell differentiation involved in immune response (GO:0002313) | 2.73096359 |
| 155 | actin nucleation (GO:0045010) | 2.72911814 |
| 156 | regulation of mast cell degranulation (GO:0043304) | 2.72321339 |
| 157 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69330395 |
| 158 | response to host immune response (GO:0052572) | 2.69221162 |
| 159 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69221162 |
| 160 | regulation of erythrocyte differentiation (GO:0045646) | 2.68478762 |
| 161 | positive regulation of interferon-beta production (GO:0032728) | 2.67495382 |
| 162 | granulocyte activation (GO:0036230) | 2.67396663 |
| 163 | positive regulation of mast cell degranulation (GO:0043306) | 2.65851444 |
| 164 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.65851444 |
| 165 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.64540372 |
| 166 | response to host (GO:0075136) | 2.64540372 |
| 167 | response to host defenses (GO:0052200) | 2.64540372 |
| 168 | positive regulation of isotype switching (GO:0045830) | 2.61809480 |
| 169 | positive thymic T cell selection (GO:0045059) | 2.60680721 |
| 170 | response to interleukin-15 (GO:0070672) | 2.59666796 |
| 171 | lymph node development (GO:0048535) | 2.59439780 |
| 172 | mast cell activation (GO:0045576) | 2.58397726 |
| 173 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.56584066 |
| 174 | negative regulation of interleukin-6 production (GO:0032715) | 2.56120321 |
| 175 | positive regulation of lamellipodium assembly (GO:0010592) | 2.53078992 |
| 176 | pinocytosis (GO:0006907) | 2.52111501 |
| 177 | regulation of mast cell activation (GO:0033003) | 2.51849492 |
| 178 | T cell homeostasis (GO:0043029) | 2.48414447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.15106297 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.83428929 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.45265273 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 3.37840797 |
| 5 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.33631050 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.15653832 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 3.01771486 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.96567689 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.93470429 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.90082282 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.85127590 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.83101768 |
| 13 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.80037740 |
| 14 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.70739671 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.69036565 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.64716758 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.63352903 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.61976894 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.54471210 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46759355 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38716003 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.37947597 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.32056727 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.29275341 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26244125 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.23061997 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20824370 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.17139630 |
| 29 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15899899 |
| 30 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.12554101 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.11678111 |
| 32 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08120174 |
| 33 | MYB_26560356_Chip-Seq_TH2_Human | 2.05433374 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.01289733 |
| 35 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.93600181 |
| 36 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93319117 |
| 37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.92621387 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89650342 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85631688 |
| 40 | MYB_26560356_Chip-Seq_TH1_Human | 1.83411396 |
| 41 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.81922667 |
| 42 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.77443212 |
| 43 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76897007 |
| 44 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.76611979 |
| 45 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75577887 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74951453 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.71835542 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.69988010 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.67235943 |
| 50 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.67168866 |
| 51 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62851441 |
| 52 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.60055601 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57846242 |
| 54 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.57804552 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.55761590 |
| 56 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52813522 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50692855 |
| 58 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.49568426 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49061448 |
| 60 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.48696741 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47879194 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46830188 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43484630 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42161179 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39672709 |
| 66 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39339922 |
| 67 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.38449679 |
| 68 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.38209901 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37313979 |
| 70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36558700 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36239179 |
| 72 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31209305 |
| 73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30182875 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30171035 |
| 75 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26181645 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.24595138 |
| 77 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.23167867 |
| 78 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.21051210 |
| 79 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.20016237 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19424362 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18620313 |
| 82 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13244622 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13014622 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12953383 |
| 85 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.12220185 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11873087 |
| 87 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.09847371 |
| 88 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09688025 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09112511 |
| 90 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06918352 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05409509 |
| 92 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.04806937 |
| 93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04396801 |
| 94 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03346572 |
| 95 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01458682 |
| 96 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01455381 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99946177 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99915056 |
| 99 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99415355 |
| 100 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98737848 |
| 101 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.98553845 |
| 102 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97412111 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96511045 |
| 104 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.96346549 |
| 105 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.96293662 |
| 106 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.96293662 |
| 107 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.95640385 |
| 108 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.95555539 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95082221 |
| 110 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94372682 |
| 111 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93518019 |
| 112 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.91827572 |
| 113 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91527555 |
| 114 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.91166848 |
| 115 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.90644473 |
| 116 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.88055552 |
| 117 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87901386 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.87664901 |
| 119 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.86917631 |
| 120 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.86739701 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86736378 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85928659 |
| 123 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85811287 |
| 124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85576889 |
| 125 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.85463487 |
| 126 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.83934087 |
| 127 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.83459955 |
| 128 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83352627 |
| 129 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.83121640 |
| 130 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83043793 |
| 131 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.82816358 |
| 132 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82440081 |
| 133 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.81863530 |
| 134 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.80057902 |
| 135 | VDR_22108803_ChIP-Seq_LS180_Human | 0.79927197 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79372986 |
| 137 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.78375460 |
| 138 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77183477 |
| 139 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76062732 |
| 140 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.75882079 |
| 141 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.75382619 |
| 142 | * RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73522703 |
| 143 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.72541292 |
| 144 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.71552558 |
| 145 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.71032065 |
| 146 | NCOR_22424771_ChIP-Seq_293T_Human | 0.69461154 |
| 147 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.68975454 |
| 148 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.68679597 |
| 149 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.68071731 |
| 150 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.67256589 |
| 151 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.67003285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.80405206 |
| 2 | MP0003436_decreased_susceptibility_to | 3.45574469 |
| 3 | MP0003303_peritoneal_inflammation | 3.40794762 |
| 4 | MP0000685_abnormal_immune_system | 3.16286877 |
| 5 | MP0009785_altered_susceptibility_to | 2.94087716 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.85108079 |
| 7 | MP0005387_immune_system_phenotype | 2.80347015 |
| 8 | MP0001790_abnormal_immune_system | 2.80347015 |
| 9 | MP0005025_abnormal_response_to | 2.79693484 |
| 10 | * MP0001800_abnormal_humoral_immune | 2.74427642 |
| 11 | MP0002419_abnormal_innate_immunity | 2.66489856 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.65085486 |
| 13 | MP0005671_abnormal_response_to | 2.60755416 |
| 14 | MP0002148_abnormal_hypersensitivity_rea | 2.54179335 |
| 15 | MP0003195_calcinosis | 2.52515609 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.51993781 |
| 17 | * MP0002723_abnormal_immune_serum | 2.47716066 |
| 18 | MP0003724_increased_susceptibility_to | 2.43471003 |
| 19 | * MP0002420_abnormal_adaptive_immunity | 2.43202350 |
| 20 | * MP0001819_abnormal_immune_cell | 2.41915955 |
| 21 | MP0002396_abnormal_hematopoietic_system | 2.40012211 |
| 22 | MP0004510_myositis | 2.39637252 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 2.33569725 |
| 24 | MP0006082_CNS_inflammation | 2.33287698 |
| 25 | MP0005058_abnormal_lysosome_morphology | 2.20860798 |
| 26 | * MP0002398_abnormal_bone_marrow | 2.19516430 |
| 27 | MP0009278_abnormal_bone_marrow | 2.17114768 |
| 28 | MP0001501_abnormal_sleep_pattern | 2.14244433 |
| 29 | MP0003646_muscle_fatigue | 2.07959161 |
| 30 | * MP0002405_respiratory_system_inflammati | 2.07901992 |
| 31 | MP0005397_hematopoietic_system_phenotyp | 2.06322819 |
| 32 | MP0001545_abnormal_hematopoietic_system | 2.06322819 |
| 33 | * MP0000716_abnormal_immune_system | 2.03241008 |
| 34 | MP0003172_abnormal_lysosome_physiology | 1.98855558 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.96909614 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.95522868 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.94766697 |
| 38 | MP0004808_abnormal_hematopoietic_stem | 1.94660021 |
| 39 | MP0004947_skin_inflammation | 1.94158017 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.89589340 |
| 41 | MP0002166_altered_tumor_susceptibility | 1.89184131 |
| 42 | * MP0009333_abnormal_splenocyte_physiolog | 1.89068889 |
| 43 | MP0008004_abnormal_stomach_pH | 1.89049354 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.86770924 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.86687948 |
| 46 | MP0002254_reproductive_system_inflammat | 1.85219887 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.84426249 |
| 48 | * MP0002722_abnormal_immune_system | 1.80945733 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.77702915 |
| 50 | * MP0001845_abnormal_inflammatory_respons | 1.76292103 |
| 51 | * MP0002429_abnormal_blood_cell | 1.76072426 |
| 52 | MP0001873_stomach_inflammation | 1.71120462 |
| 53 | MP0001853_heart_inflammation | 1.69954388 |
| 54 | MP0000490_abnormal_crypts_of | 1.67841861 |
| 55 | MP0005174_abnormal_tail_pigmentation | 1.66195925 |
| 56 | MP0009840_abnormal_foam_cell | 1.58541870 |
| 57 | MP0002006_tumorigenesis | 1.54488121 |
| 58 | MP0010352_gastrointestinal_tract_polyps | 1.49932545 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.45950183 |
| 60 | MP0003448_altered_tumor_morphology | 1.44980673 |
| 61 | MP0000343_altered_response_to | 1.43961723 |
| 62 | MP0008469_abnormal_protein_level | 1.40803620 |
| 63 | MP0003191_abnormal_cellular_cholesterol | 1.36963909 |
| 64 | MP0002933_joint_inflammation | 1.34489700 |
| 65 | * MP0000703_abnormal_thymus_morphology | 1.30257154 |
| 66 | MP0000858_altered_metastatic_potential | 1.30189898 |
| 67 | MP0003075_altered_response_to | 1.28678656 |
| 68 | MP0003866_abnormal_defecation | 1.28551692 |
| 69 | MP0005310_abnormal_salivary_gland | 1.23355592 |
| 70 | MP0004043_abnormal_pH_regulation | 1.23076870 |
| 71 | MP0001851_eye_inflammation | 1.18064667 |
| 72 | MP0002837_dystrophic_cardiac_calcinosis | 1.15353538 |
| 73 | MP0003806_abnormal_nucleotide_metabolis | 1.14852583 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 1.10526408 |
| 75 | MP0010307_abnormal_tumor_latency | 1.08473813 |
| 76 | MP0005076_abnormal_cell_differentiation | 1.08352733 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 1.06787539 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.06364573 |
| 79 | MP0003566_abnormal_cell_adhesion | 1.04661239 |
| 80 | MP0002019_abnormal_tumor_incidence | 0.99610631 |
| 81 | MP0001919_abnormal_reproductive_system | 0.98957593 |
| 82 | MP0005023_abnormal_wound_healing | 0.98937659 |
| 83 | MP0005390_skeleton_phenotype | 0.98894707 |
| 84 | MP0005166_decreased_susceptibility_to | 0.95188975 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.94724220 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.88776551 |
| 87 | MP0005266_abnormal_metabolism | 0.88673079 |
| 88 | MP0003878_abnormal_ear_physiology | 0.88367333 |
| 89 | MP0005377_hearing/vestibular/ear_phenot | 0.88367333 |
| 90 | MP0009764_decreased_sensitivity_to | 0.86210056 |
| 91 | MP0003828_pulmonary_edema | 0.86079320 |
| 92 | MP0005535_abnormal_body_temperature | 0.85993988 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.83078855 |
| 94 | MP0000249_abnormal_blood_vessel | 0.82723545 |
| 95 | MP0009763_increased_sensitivity_to | 0.82125317 |
| 96 | MP0005164_abnormal_response_to | 0.79090077 |
| 97 | MP0001663_abnormal_digestive_system | 0.78038773 |
| 98 | MP0005165_increased_susceptibility_to | 0.75013508 |
| 99 | MP0000371_diluted_coat_color | 0.74686843 |
| 100 | MP0005319_abnormal_enzyme/_coenzyme | 0.74621734 |
| 101 | MP0003045_fibrosis | 0.72012389 |
| 102 | MP0005084_abnormal_gallbladder_morpholo | 0.71923090 |
| 103 | MP0003705_abnormal_hypodermis_morpholog | 0.71204934 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.70049514 |
| 105 | MP0001764_abnormal_homeostasis | 0.69521515 |
| 106 | MP0002733_abnormal_thermal_nociception | 0.68599478 |
| 107 | MP0002132_abnormal_respiratory_system | 0.67926929 |
| 108 | MP0000313_abnormal_cell_death | 0.66997514 |
| 109 | MP0006054_spinal_hemorrhage | 0.66792440 |
| 110 | MP0003795_abnormal_bone_structure | 0.65356723 |
| 111 | MP0001542_abnormal_bone_strength | 0.64856680 |
| 112 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64851812 |
| 113 | MP0003279_aneurysm | 0.64672306 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.64436939 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.64271219 |
| 116 | MP0008873_increased_physiological_sensi | 0.63844528 |
| 117 | MP0003690_abnormal_glial_cell | 0.63780626 |
| 118 | MP0000604_amyloidosis | 0.63246202 |
| 119 | MP0003091_abnormal_cell_migration | 0.63160751 |
| 120 | MP0003183_abnormal_peptide_metabolism | 0.62808780 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.62501520 |
| 122 | MP0003693_abnormal_embryo_hatching | 0.59931676 |
| 123 | MP0000477_abnormal_intestine_morphology | 0.59669639 |
| 124 | MP0003077_abnormal_cell_cycle | 0.59321216 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.58871924 |
| 126 | MP0005410_abnormal_fertilization | 0.58824907 |
| 127 | MP0000598_abnormal_liver_morphology | 0.58094465 |
| 128 | MP0001348_abnormal_lacrimal_gland | 0.58088205 |
| 129 | MP0008007_abnormal_cellular_replicative | 0.57700214 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.55770511 |
| 131 | MP0002095_abnormal_skin_pigmentation | 0.55732708 |
| 132 | MP0001970_abnormal_pain_threshold | 0.55649874 |
| 133 | MP0004019_abnormal_vitamin_homeostasis | 0.55321797 |
| 134 | MP0000767_abnormal_smooth_muscle | 0.55244947 |
| 135 | MP0001915_intracranial_hemorrhage | 0.54752571 |
| 136 | MP0005448_abnormal_energy_balance | 0.54122072 |
| 137 | MP0002735_abnormal_chemical_nociception | 0.53817484 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.66572782 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.36135408 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.81855542 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.63170882 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.21702755 |
| 6 | Myositis (HP:0100614) | 4.02564188 |
| 7 | Recurrent fungal infections (HP:0002841) | 3.96484187 |
| 8 | Keratoconjunctivitis sicca (HP:0001097) | 3.95329447 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.93429980 |
| 10 | Chronic otitis media (HP:0000389) | 3.92791460 |
| 11 | Parakeratosis (HP:0001036) | 3.90040127 |
| 12 | Nasal polyposis (HP:0100582) | 3.89715160 |
| 13 | Keratoconjunctivitis (HP:0001096) | 3.87391576 |
| 14 | Abnormality of the nasal mucosa (HP:0000433) | 3.70808422 |
| 15 | IgM deficiency (HP:0002850) | 3.69321301 |
| 16 | Pustule (HP:0200039) | 3.65637201 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.61925704 |
| 18 | Mediastinal lymphadenopathy (HP:0100721) | 3.60441451 |
| 19 | Cellulitis (HP:0100658) | 3.59674585 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.48375402 |
| 21 | Abnormality of B cell number (HP:0010975) | 3.47365903 |
| 22 | Gangrene (HP:0100758) | 3.47024453 |
| 23 | Recurrent skin infections (HP:0001581) | 3.44719791 |
| 24 | Recurrent viral infections (HP:0004429) | 3.43730161 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.41035659 |
| 26 | Thrombocytosis (HP:0001894) | 3.41028352 |
| 27 | Prolonged bleeding time (HP:0003010) | 3.28190591 |
| 28 | Petechiae (HP:0000967) | 3.24792173 |
| 29 | Dysostosis multiplex (HP:0000943) | 3.22751891 |
| 30 | Recurrent bronchitis (HP:0002837) | 3.12403728 |
| 31 | Chronic obstructive pulmonary disease (HP:0006510) | 3.11720271 |
| 32 | Obstructive lung disease (HP:0006536) | 3.11720271 |
| 33 | Recurrent cutaneous fungal infections (HP:0011370) | 3.07171187 |
| 34 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.07171187 |
| 35 | B lymphocytopenia (HP:0010976) | 3.04289156 |
| 36 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.01435945 |
| 37 | Stomach cancer (HP:0012126) | 3.00516090 |
| 38 | Stomatitis (HP:0010280) | 3.00419736 |
| 39 | Interstitial pulmonary disease (HP:0006530) | 2.99430934 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.95619918 |
| 41 | Autoimmune hemolytic anemia (HP:0001890) | 2.95341879 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.94645156 |
| 43 | Gastrointestinal inflammation (HP:0004386) | 2.93803414 |
| 44 | Meningitis (HP:0001287) | 2.92126896 |
| 45 | Orchitis (HP:0100796) | 2.92043544 |
| 46 | Increased IgM level (HP:0003496) | 2.91946717 |
| 47 | Mucopolysacchariduria (HP:0008155) | 2.84752258 |
| 48 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.84752258 |
| 49 | Encephalitis (HP:0002383) | 2.83946704 |
| 50 | Epistaxis (HP:0000421) | 2.78859800 |
| 51 | Gingivitis (HP:0000230) | 2.74598815 |
| 52 | Colitis (HP:0002583) | 2.70263360 |
| 53 | Tetany (HP:0001281) | 2.69482600 |
| 54 | Vasculitis (HP:0002633) | 2.68973949 |
| 55 | Polydipsia (HP:0001959) | 2.67166083 |
| 56 | Abnormal drinking behavior (HP:0030082) | 2.67166083 |
| 57 | Abnormal platelet function (HP:0011869) | 2.66684692 |
| 58 | Impaired platelet aggregation (HP:0003540) | 2.66684692 |
| 59 | Abnormality of T cell physiology (HP:0011840) | 2.66532716 |
| 60 | Congenital stationary night blindness (HP:0007642) | 2.66155514 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.65568560 |
| 62 | Loss of speech (HP:0002371) | 2.64174601 |
| 63 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.63458688 |
| 64 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.63458688 |
| 65 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.63458688 |
| 66 | Hypomagnesemia (HP:0002917) | 2.60986473 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.58383816 |
| 68 | Mesangial abnormality (HP:0001966) | 2.56517450 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.53350630 |
| 70 | Joint swelling (HP:0001386) | 2.51419479 |
| 71 | Polyneuropathy (HP:0001271) | 2.51230803 |
| 72 | Glomerulonephritis (HP:0000099) | 2.49588053 |
| 73 | Periodontitis (HP:0000704) | 2.45868461 |
| 74 | Leukocytosis (HP:0001974) | 2.44346306 |
| 75 | Gingival bleeding (HP:0000225) | 2.43705667 |
| 76 | Abnormality of T cells (HP:0002843) | 2.42880678 |
| 77 | Anorexia (HP:0002039) | 2.41141278 |
| 78 | Abnormality of T cell number (HP:0011839) | 2.39683648 |
| 79 | Abnormality of the pleura (HP:0002103) | 2.38766222 |
| 80 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.37670105 |
| 81 | Abnormality of glycolipid metabolism (HP:0010969) | 2.37670105 |
| 82 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.37670105 |
| 83 | Arterial thrombosis (HP:0004420) | 2.33011317 |
| 84 | Abolished electroretinogram (ERG) (HP:0000550) | 2.32241621 |
| 85 | Enlarged epiphyses (HP:0010580) | 2.30792041 |
| 86 | Albinism (HP:0001022) | 2.29706049 |
| 87 | Retrobulbar optic neuritis (HP:0100654) | 2.28954350 |
| 88 | Optic neuritis (HP:0100653) | 2.28954350 |
| 89 | Generalized aminoaciduria (HP:0002909) | 2.28377527 |
| 90 | Menorrhagia (HP:0000132) | 2.28303790 |
| 91 | Hematochezia (HP:0002573) | 2.28063923 |
| 92 | Mutism (HP:0002300) | 2.28006103 |
| 93 | T lymphocytopenia (HP:0005403) | 2.27859333 |
| 94 | Thyroiditis (HP:0100646) | 2.27857777 |
| 95 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.27527588 |
| 96 | Severe combined immunodeficiency (HP:0004430) | 2.27425790 |
| 97 | Thoracic kyphosis (HP:0002942) | 2.26997330 |
| 98 | IgG deficiency (HP:0004315) | 2.26130477 |
| 99 | Emphysema (HP:0002097) | 2.25037826 |
| 100 | Urticaria (HP:0001025) | 2.24259004 |
| 101 | Chest pain (HP:0100749) | 2.21424970 |
| 102 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.17154881 |
| 103 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.16956406 |
| 104 | Osteomyelitis (HP:0002754) | 2.16565124 |
| 105 | Vertigo (HP:0002321) | 2.16190813 |
| 106 | Agammaglobulinemia (HP:0004432) | 2.16164967 |
| 107 | Increased IgE level (HP:0003212) | 2.15684362 |
| 108 | Pulmonary infiltrates (HP:0002113) | 2.15628309 |
| 109 | Disinhibition (HP:0000734) | 2.15224236 |
| 110 | Abnormal number of erythroid precursors (HP:0012131) | 2.15082572 |
| 111 | Lymphopenia (HP:0001888) | 2.14657346 |
| 112 | Hemoptysis (HP:0002105) | 2.13886411 |
| 113 | Hypergammaglobulinemia (HP:0010702) | 2.13836054 |
| 114 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.13198441 |
| 115 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.13004788 |
| 116 | Spondylolisthesis (HP:0003302) | 2.12121205 |
| 117 | Purpura (HP:0000979) | 2.11837447 |
| 118 | Increased density of long bones (HP:0006392) | 2.10115241 |
| 119 | Joint stiffness (HP:0001387) | 2.07863696 |
| 120 | Eosinophilia (HP:0001880) | 2.07812742 |
| 121 | Gastrointestinal stroma tumor (HP:0100723) | 2.06809346 |
| 122 | Cheilitis (HP:0100825) | 2.05388337 |
| 123 | Combined immunodeficiency (HP:0005387) | 2.04714703 |
| 124 | Gastrointestinal infarctions (HP:0005244) | 2.02702904 |
| 125 | Restrictive lung disease (HP:0002091) | 2.02415310 |
| 126 | Reticulocytopenia (HP:0001896) | 2.01301143 |
| 127 | Keratitis (HP:0000491) | 2.00462469 |
| 128 | Abnormality of magnesium homeostasis (HP:0004921) | 2.00250681 |
| 129 | Alveolar cell carcinoma (HP:0006519) | 1.99406328 |
| 130 | Abnormality of the pericardium (HP:0001697) | 1.97536165 |
| 131 | Cervical subluxation (HP:0003308) | 1.97484373 |
| 132 | Fatigue (HP:0012378) | 1.96483746 |
| 133 | Abnormality of the thoracic spine (HP:0100711) | 1.95928025 |
| 134 | Vertebral compression fractures (HP:0002953) | 1.95659414 |
| 135 | Asymmetric septal hypertrophy (HP:0001670) | 1.95193398 |
| 136 | Chronic sinusitis (HP:0011109) | 1.95070027 |
| 137 | Abnormality of eosinophils (HP:0001879) | 1.94175607 |
| 138 | Peritonitis (HP:0002586) | 1.93598196 |
| 139 | Abnormality of midbrain morphology (HP:0002418) | 1.92886146 |
| 140 | Molar tooth sign on MRI (HP:0002419) | 1.92886146 |
| 141 | Clumsiness (HP:0002312) | 1.92368604 |
| 142 | Polyuria (HP:0000103) | 1.91985117 |
| 143 | Deformed sella turcica (HP:0002681) | 1.91586245 |
| 144 | Nausea (HP:0002018) | 1.91048650 |
| 145 | Adactyly (HP:0009776) | 1.90711596 |
| 146 | Episodic fever (HP:0001954) | 1.89642352 |
| 147 | Pendular nystagmus (HP:0012043) | 1.88904832 |
| 148 | Increased serum ferritin (HP:0003281) | 1.88724846 |
| 149 | Abnormality of lateral ventricle (HP:0030047) | 1.85287900 |
| 150 | Pancreatic cysts (HP:0001737) | 1.82092176 |
| 151 | Erythroderma (HP:0001019) | 1.79693168 |
| 152 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.78441312 |
| 153 | Nuclear cataract (HP:0100018) | 1.77481987 |
| 154 | 3-Methylglutaconic aciduria (HP:0003535) | 1.76358484 |
| 155 | Acne (HP:0001061) | 1.75082369 |
| 156 | Progressive neurologic deterioration (HP:0002344) | 1.74836762 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.57076029 |
| 2 | ADRBK2 | 3.62568449 |
| 3 | GRK7 | 3.46284592 |
| 4 | ERN1 | 2.97726156 |
| 5 | KIT | 2.91967864 |
| 6 | BMPR1B | 2.76961811 |
| 7 | TBK1 | 2.68587979 |
| 8 | BLK | 2.58116821 |
| 9 | TYK2 | 2.40147130 |
| 10 | EEF2K | 2.37990349 |
| 11 | NME2 | 2.34292510 |
| 12 | ZAP70 | 2.19642358 |
| 13 | JAK3 | 2.19437210 |
| 14 | PIM2 | 2.08300611 |
| 15 | RIPK4 | 2.03601027 |
| 16 | TRIB3 | 2.00902718 |
| 17 | PKN2 | 1.96046270 |
| 18 | CSF1R | 1.91543037 |
| 19 | IKBKE | 1.91182070 |
| 20 | BTK | 1.88000665 |
| 21 | IRAK1 | 1.87924677 |
| 22 | TXK | 1.86947220 |
| 23 | MAP3K10 | 1.82049449 |
| 24 | IRAK4 | 1.81344314 |
| 25 | TLK1 | 1.80302850 |
| 26 | IKBKB | 1.77963618 |
| 27 | FRK | 1.77264308 |
| 28 | MAP3K14 | 1.77001989 |
| 29 | BMPR2 | 1.75032555 |
| 30 | TGFBR2 | 1.74871150 |
| 31 | DDR2 | 1.64816621 |
| 32 | TAOK2 | 1.64086780 |
| 33 | GRK6 | 1.60191353 |
| 34 | FLT3 | 1.53575858 |
| 35 | STK10 | 1.51154234 |
| 36 | FES | 1.49976994 |
| 37 | SYK | 1.49699904 |
| 38 | MAP2K3 | 1.49285355 |
| 39 | IRAK3 | 1.46640024 |
| 40 | TEC | 1.46496139 |
| 41 | DAPK2 | 1.46123641 |
| 42 | HCK | 1.45639041 |
| 43 | LRRK2 | 1.44413032 |
| 44 | MATK | 1.38585360 |
| 45 | CSK | 1.38101630 |
| 46 | PIM1 | 1.38051833 |
| 47 | RPS6KA4 | 1.38019335 |
| 48 | BCKDK | 1.33154518 |
| 49 | TAOK3 | 1.29083548 |
| 50 | KDR | 1.27648024 |
| 51 | LCK | 1.26536562 |
| 52 | JAK1 | 1.25282456 |
| 53 | MAP3K11 | 1.24005510 |
| 54 | SCYL2 | 1.18174379 |
| 55 | EPHB1 | 1.05271598 |
| 56 | LYN | 1.05057294 |
| 57 | EPHA3 | 1.02643952 |
| 58 | WNK4 | 1.02546264 |
| 59 | BMX | 1.01500755 |
| 60 | MAP4K2 | 0.98612884 |
| 61 | PKN1 | 0.97697060 |
| 62 | GRK1 | 0.97188995 |
| 63 | CHUK | 0.96367549 |
| 64 | FGFR4 | 0.95231220 |
| 65 | CLK1 | 0.95114096 |
| 66 | SIK2 | 0.86691620 |
| 67 | ZAK | 0.86142764 |
| 68 | RIPK1 | 0.85179497 |
| 69 | ITK | 0.84115236 |
| 70 | MAP2K6 | 0.82287191 |
| 71 | MAP3K13 | 0.82249134 |
| 72 | TGFBR1 | 0.80798787 |
| 73 | JAK2 | 0.80491747 |
| 74 | RPS6KA6 | 0.78621926 |
| 75 | INSRR | 0.77925449 |
| 76 | CDC42BPA | 0.77069194 |
| 77 | ACVR1B | 0.75042332 |
| 78 | PAK4 | 0.70119267 |
| 79 | RPS6KL1 | 0.69617187 |
| 80 | RPS6KC1 | 0.69617187 |
| 81 | PRKG2 | 0.68253537 |
| 82 | MAP3K3 | 0.66522164 |
| 83 | NLK | 0.66290957 |
| 84 | NEK2 | 0.64870817 |
| 85 | TESK2 | 0.64787853 |
| 86 | CDK4 | 0.64664792 |
| 87 | CDK8 | 0.63922488 |
| 88 | EIF2AK2 | 0.63876074 |
| 89 | FGFR3 | 0.62830049 |
| 90 | PTK6 | 0.62787241 |
| 91 | FGR | 0.61031595 |
| 92 | MAPKAPK3 | 0.59788607 |
| 93 | IRAK2 | 0.59376668 |
| 94 | MST1R | 0.56714647 |
| 95 | MAPK4 | 0.56094324 |
| 96 | ALK | 0.55375141 |
| 97 | TAOK1 | 0.54831587 |
| 98 | TTN | 0.54400647 |
| 99 | RPS6KB2 | 0.53664652 |
| 100 | MAPK15 | 0.53504056 |
| 101 | CDK12 | 0.53481514 |
| 102 | NME1 | 0.53438703 |
| 103 | CAMK1D | 0.50148476 |
| 104 | MAP3K5 | 0.49922733 |
| 105 | DAPK1 | 0.49817066 |
| 106 | WNK3 | 0.49627767 |
| 107 | MARK3 | 0.49611426 |
| 108 | EGFR | 0.45741200 |
| 109 | RAF1 | 0.45511793 |
| 110 | HIPK2 | 0.45170453 |
| 111 | TYRO3 | 0.43898900 |
| 112 | CDK7 | 0.43813362 |
| 113 | PRKCQ | 0.43294262 |
| 114 | MAP3K8 | 0.43179135 |
| 115 | MAPKAPK2 | 0.42167587 |
| 116 | TRPM7 | 0.42075282 |
| 117 | MKNK2 | 0.41919779 |
| 118 | TNK2 | 0.40716129 |
| 119 | MKNK1 | 0.40136133 |
| 120 | RPS6KA5 | 0.39845742 |
| 121 | ABL1 | 0.39804550 |
| 122 | ABL2 | 0.37874760 |
| 123 | CDK6 | 0.37827588 |
| 124 | MAP3K6 | 0.36769505 |
| 125 | PRKCI | 0.36339259 |
| 126 | DYRK3 | 0.36105290 |
| 127 | DAPK3 | 0.36045285 |
| 128 | CAMKK2 | 0.35350569 |
| 129 | MAP3K1 | 0.34760282 |
| 130 | STK4 | 0.34316597 |
| 131 | PRKCH | 0.32440437 |
| 132 | PRKCD | 0.32132800 |
| 133 | INSR | 0.31847498 |
| 134 | RPS6KA1 | 0.31776260 |
| 135 | MOS | 0.30574559 |
| 136 | STK3 | 0.27771974 |
| 137 | CSNK1A1 | 0.27655414 |
| 138 | STK24 | 0.26052526 |
| 139 | IGF1R | 0.25212979 |
| 140 | ADRBK1 | 0.20377127 |
| 141 | MAPKAPK5 | 0.20261887 |
| 142 | PRKCE | 0.17611085 |
| 143 | VRK1 | 0.17379298 |
| 144 | MAPK3 | 0.16365274 |
| 145 | PDK1 | 0.15561966 |
| 146 | CDK9 | 0.15327950 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02579242 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.54801484 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.40157068 |
| 4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.33723717 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.32878787 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29479962 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11088839 |
| 8 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.09986468 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.01099624 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.93871647 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 1.90457231 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.90147207 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.89155376 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.88609390 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.88323094 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.82751265 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81376060 |
| 18 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.79830302 |
| 19 | Malaria_Homo sapiens_hsa05144 | 1.79543152 |
| 20 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.77607464 |
| 21 | Ribosome_Homo sapiens_hsa03010 | 1.75014790 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.66813714 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.66213703 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.65542823 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.60406397 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.59200210 |
| 27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.59163479 |
| 28 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.49429882 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.49176253 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.48571702 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48350182 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.48313514 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.47141721 |
| 34 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.46087122 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42954646 |
| 36 | Apoptosis_Homo sapiens_hsa04210 | 1.42492152 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.38217811 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.33442842 |
| 39 | Hepatitis B_Homo sapiens_hsa05161 | 1.32778159 |
| 40 | DNA replication_Homo sapiens_hsa03030 | 1.30798210 |
| 41 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.29478995 |
| 42 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.26155116 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23823405 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.23091668 |
| 45 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.16528315 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.16273508 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15882915 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15192846 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.12636979 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12278958 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08546457 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05062718 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00870980 |
| 54 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.97460773 |
| 55 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96657106 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.95282829 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95031709 |
| 58 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94297148 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92432880 |
| 60 | Base excision repair_Homo sapiens_hsa03410 | 0.89947949 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89162243 |
| 62 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87106065 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 0.83515816 |
| 64 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83177463 |
| 65 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.81761363 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78991066 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78120259 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.77482270 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75992499 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.75513705 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75409096 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74321960 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.73582163 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73210834 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.73209317 |
| 76 | Mismatch repair_Homo sapiens_hsa03430 | 0.67704071 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.66598828 |
| 78 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.64395912 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64248700 |
| 80 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64131163 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64043202 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61718105 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58389705 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58354022 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57839905 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57503324 |
| 87 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56368350 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.56172058 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55524228 |
| 90 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.54841459 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53885217 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52989484 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52746137 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.52371857 |
| 95 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49309887 |
| 96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.48873793 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46105295 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.45222299 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.45055621 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44909506 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44757345 |
| 102 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43174816 |
| 103 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42993781 |
| 104 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.42869203 |
| 105 | Spliceosome_Homo sapiens_hsa03040 | 0.41178730 |
| 106 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.40281112 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.39843143 |
| 108 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.39820727 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39712561 |
| 110 | Endocytosis_Homo sapiens_hsa04144 | 0.39205621 |
| 111 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.38780732 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38343129 |
| 113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37462304 |
| 114 | Homologous recombination_Homo sapiens_hsa03440 | 0.36283345 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35229670 |
| 116 | Thyroid cancer_Homo sapiens_hsa05216 | 0.34760809 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.34651340 |
| 118 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34577364 |
| 119 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34553563 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.34003813 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.33898274 |
| 122 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33704496 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33357933 |
| 124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30935243 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.26181506 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.25651811 |
| 127 | Proteasome_Homo sapiens_hsa03050 | 0.19756115 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.18283180 |
| 129 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.17933615 |
| 130 | Salivary secretion_Homo sapiens_hsa04970 | 0.17139535 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.17035524 |
| 132 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.16986675 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.13191604 |
| 134 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.08706552 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07447790 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03687933 |
| 137 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.03507263 |

